Irinotecan in chemotherapy of advanced colorectal cancer
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 3
Abstract
Irinotecan (CPT-11) is a semisynthetic derivative of camptothecin, which effectiveness and toxicity have been extensively investigated in colorectal cancer (crc) and in this type of neoplasm it has wide application. Promising outcomes of early trials with CPT-11 and crc patients have been confirmed in randomized trials. In 5-fu-refractory crc patients, irinotecan showed advantage over best supportive care and infusions of 5-fu. Trials with CPT-11 in the first line treatment of crc also reported highest efficacy of this agent than 5-fu and leucovorin. Several trials have been conducted with irinotecan in schedules with targeted therapy agents and others, like oxaliplatin and oral precursor of 5-fu, capecytabine. An early trial with the oral form of irinotecan has also been reported.
Authors and Affiliations
Krzysztof Leśniewski-Kmak
Keywords
Related Articles
- EP ID EP118332
- DOI -
- Views 53
- Downloads 0
Treatment of advanced invasive Thymomas in experience of Oncology Department at Regional Centre of Lung Diseases in Poznań and Department of Thoracic Surgery, Poznań University of Medical Sciences
Introduction: Thymoma is a rare neoplasm, deriving from epithelial tissue of Thymus. ADOC, PAC, PE and VIP are most frequently used combintions. Materials and method: Retrospective analysis including 13 patients treated...
Przednia resekcja odbytnicy – wybrane aspekty jakości życia chorych
Rak jelita grubego jest narastającym problemem nie tylko onkologicznym, ale przede wszystkim zdrowotnym współczesnego społeczeństwa w Polsce i na świecie. Badania nad jakością życia w chorobach przewlekłych są cennym źró...
Diagnostyka endoskopowa raka jelita grubego
Wzrastająca zachorowalność na raka jelita grubego w populacji polskiej wymusza doskonalenie starych i poszukiwanie nowych, bardziej skutecznych metod diagnostycznych przydatnych do jego rozpoznania. Na poprawę wyników le...
Principles of diagnosis and treatment of patients with head and neck squamous cancer
Head and neck squamous cell carcinomas (HNSCC) arise in the lips, oral cavity, larynx, pharynx, nasal cavity, paranasal sinuses and salivary glands. HNSCC constitute 10 % of all malignant cancers, the incidence in males...
Nasopharyngeal melanoma treated with radiotherapy
Primary mucosal melanoma of head and neck should be treated surgically with optional adjuvant radiotherapy according to several authors. We have treated unoperable nasopharyngeal melanoma with 3D teletherapy (70Gy/2Gy/7w...